| AIIRD(autoimmune inflammatory rheumatic diseases) |
EULAR より |
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases |
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update |
ACR より |
2022 Guideline for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases |
COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases (RMDs) |
COVID-19 Clinical Guidance for Adult Patients with Rheumatic Diseases |
COVID-19 Clinical Guidance for Pediatric Patients |
ACR Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID‐19 Pandemic: Version 2 |
Clinical Guidance Summary for Pediatric Patients with MIS-C Associated with SARS-CoV-2 and Hyperinflammation in COVID-19 |
ACR Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 3 |
日本リウマチ学会 より |
新型コロナウイルス（COVID-19）・ワクチンについて（医師向け情報） (2022.6.7) |
|---|
